Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection-Reference-Cited by-同舟云学术

Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection

Published:2023-10-27 Issue:12 Volume:42 Page:1485-1497
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Corbella Laura^ORCID,Fernández-Ruiz Mario^ORCID,Ruiz-Ruigómez María^ORCID,Rodríguez-Goncer Isabel^ORCID,Silva José Tiago^ORCID,Hernández-Jiménez Pilar^ORCID,López-Medrano Francisco^ORCID,Lizasoain Manuel,Villa Jennifer^ORCID,Aguado José María^ORCID,San-Juan Rafael^ORCID

Funder

Instituto de Salud Carlos III

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10096-023-04675-w.pdf

Reference47 articles.

1. Antimicrobial Resistance Collaborators (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399(10325):629–655. https://doi.org/10.1016/S0140-6736(21)02724-0. (Erratum in: Lancet. 2022 Oct 1;400(10358):1102)

2. Lee CR, Lee JH, Park KS, Kim YB, Jeong BC, Lee SH (2016) Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front Microbiol 7:895. https://doi.org/10.3389/fmicb-2016-00895

3. Nordmann P, Poirel L (2019) Epidemiology and diagnostics of carbapenem resistance in Gram-negative bacteria. Clin Infect Dis 69(Supplement_7):521–28. https://doi.org/10.1093/cid/ciz824

4. de Jonge BL, Karlowsky JA, Kazmierczak KM, Biedenbach DJ, Sahm DF, Nichols WW (2016) In Vitro Susceptibility to Ceftazidime-avibactam of carbapenem-nonsusceptible enterobacteriaceae isolates collected during the INFORM Global Surveillance Study (2012 to 2014). Antimicrob Agents Chemother 60(5):3163–3169. https://doi.org/10.1128/AAC.03042-15

5. Oteo J, Ortega A, Bartolomé R, Bou G, Conejo C, Fernández-Martínez M, GEIH-GEMARA (SEIMC) and REIPI et al (2015) Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem. Antimicrob Agents Chemother 59(6):3406–12. https://doi.org/10.1128/AAC.00086-15